Using personalized medicine to avoid resistance to leukemia treatment ...Middle East

- News
Using personalized medicine to avoid resistance to leukemia treatment
T-cell acute lymphoblastic leukemia is an aggressive cancer type that mostly affects children. The standard treatment is chemotherapy, but about one in four patients do not respond or develop resistance to this. Now, researchers from the University of Copenhagen have found a combination treatment that could benefit these patients and increase the survival rate.

Hence then, the article about using personalized medicine to avoid resistance to leukemia treatment was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Using personalized medicine to avoid resistance to leukemia treatment )

Apple Storegoogle play

Last updated :

Also on site :